Weight loss jabs are transforming obesity treatment, but without access to affordable healthy food and ongoing support they could widen health inequalities in the UK, experts have warned.
The injections, also known as GLP-1 receptor agonists, are taken by an estimated 2.4 million Britons and work by mimicking the natural hormone which regulates blood sugar, appetite and digestion.
